Updated logo UPDATED Back to feed
deep tech GeekWire June 17, 2026

Seattle biotech heavy-hitters emerge from stealth with $46M for next-gen migraine treatments

Seattle biotech heavy-hitters emerge from stealth with $46M for next-gen migraine treatments
AI Summary

Vedana’s lealdership team, from left: Dr. Rob Lenz, board chair; Leon Garcia, co-founder and chief scientific officer; Anurag Agarwal, co-founder and CEO; and Dr. Ernesto Aycardi, chief medical officer.

0 views
Read full article
Read it on Updated — Tech News. Ahead of the Curve.
Discussion
Sign in to join the discussion.
Loading comments…